Correlation Between Sarthak Metals and Par Drugs

Can any of the company-specific risk be diversified away by investing in both Sarthak Metals and Par Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarthak Metals and Par Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarthak Metals Limited and Par Drugs And, you can compare the effects of market volatilities on Sarthak Metals and Par Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarthak Metals with a short position of Par Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarthak Metals and Par Drugs.

Diversification Opportunities for Sarthak Metals and Par Drugs

-0.43

Correlation Coefficient

Sarthak Metals  Par Drugs

Very good diversification

The 3 months correlation between Sarthak and Par is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Sarthak Metals Limited and Par Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Par Drugs And and Sarthak Metals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarthak Metals Limited are associated (or correlated) with Par Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Par Drugs And has no effect on the direction of Sarthak Metals i.e., Sarthak Metals and Par Drugs go up and down completely randomly.

Pair Corralation between Sarthak Metals and Par Drugs

Assuming the 90 days trading horizon Sarthak Metals Limited is expected to under-perform the Par Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Sarthak Metals Limited is 1.42 times less risky than Par Drugs. The stock trades about -0.03 of its potential returns per unit of risk. The Par Drugs And is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  23,930  in Par Drugs And on September 5, 2024 and sell it today you would earn a total of  3,950  from holding Par Drugs And or generate 16.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sarthak Metals Limited  vs.  Par Drugs And

Sarthak Metals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sarthak Metals Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Par Drugs And

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Par Drugs And are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent technical and fundamental indicators, Par Drugs exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sarthak Metals and Par Drugs

The main advantage of trading using opposite Sarthak Metals and Par Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarthak Metals position performs unexpectedly, Par Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Par Drugs will offset losses from the drop in Par Drugs' long position.

The idea behind Sarthak Metals Limited and Par Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.